1. Home
  2. ODP vs AUPH Comparison

ODP vs AUPH Comparison

Compare ODP & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The ODP Corporation

ODP

The ODP Corporation

HOLD

Current Price

$28.00

Market Cap

842.4M

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.78

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ODP
AUPH
Founded
1986
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
842.4M
1.6B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
ODP
AUPH
Price
$28.00
$15.78
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$28.00
$17.25
AVG Volume (30 Days)
1.1M
1.6M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
$6,534,000,000.00
$265,808,000.00
Revenue This Year
N/A
$21.22
Revenue Next Year
N/A
$15.40
P/E Ratio
N/A
$28.81
Revenue Growth
N/A
20.62
52 Week Low
$11.85
$6.55
52 Week High
$28.84
$16.48

Technical Indicators

Market Signals
Indicator
ODP
AUPH
Relative Strength Index (RSI) 70.56 59.93
Support Level $27.91 $15.15
Resistance Level $27.99 $16.03
Average True Range (ATR) 0.04 0.50
MACD -0.04 -0.13
Stochastic Oscillator 100.00 64.33

Price Performance

Historical Comparison
ODP
AUPH

About ODP The ODP Corporation

The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on international operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and spend management tools. Revenue stems from the Veyer division.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: